IRIS - Res&Arch Institutional Research Information System - Research & Archive

MORETTI, Sonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.812
EU - Europa 1.442
AS - Asia 1.225
SA - Sud America 211
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 5
Totale 4.716
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.782
SG - Singapore 538
UA - Ucraina 278
SE - Svezia 195
CN - Cina 180
IE - Irlanda 180
FR - Francia 178
BR - Brasile 168
HK - Hong Kong 152
RU - Federazione Russa 149
DE - Germania 126
IT - Italia 125
VN - Vietnam 112
KR - Corea 88
FI - Finlandia 75
GB - Regno Unito 44
IN - India 28
BD - Bangladesh 25
IQ - Iraq 17
BE - Belgio 16
PK - Pakistan 16
AR - Argentina 13
RO - Romania 13
AT - Austria 12
TR - Turchia 12
MX - Messico 11
PL - Polonia 11
CA - Canada 10
CH - Svizzera 10
CO - Colombia 9
NL - Olanda 9
SA - Arabia Saudita 9
ID - Indonesia 7
UZ - Uzbekistan 7
EC - Ecuador 5
EU - Europa 5
JP - Giappone 5
CZ - Repubblica Ceca 4
GR - Grecia 4
LB - Libano 4
VE - Venezuela 4
BG - Bulgaria 3
CR - Costa Rica 3
EG - Egitto 3
ES - Italia 3
KE - Kenya 3
KZ - Kazakistan 3
LT - Lituania 3
MY - Malesia 3
PH - Filippine 3
PY - Paraguay 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
GT - Guatemala 2
IL - Israele 2
KG - Kirghizistan 2
MA - Marocco 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
ZA - Sudafrica 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BZ - Belize 1
CM - Camerun 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
JO - Giordania 1
LK - Sri Lanka 1
LR - Liberia 1
LU - Lussemburgo 1
MK - Macedonia 1
ML - Mali 1
MT - Malta 1
NG - Nigeria 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SR - Suriname 1
TH - Thailandia 1
Totale 4.716
Salva come PNG Salva come JPEG
Città #
Singapore 383
Chandler 276
Dublin 180
San Jose 165
Hong Kong 152
Jacksonville 152
Ashburn 103
San Mateo 100
Boardman 72
Santa Clara 71
Ann Arbor 69
Seoul 69
Dong Ket 66
Munich 56
Medford 52
Beijing 50
Moscow 49
Princeton 49
Lauterbourg 45
Altamura 43
Wilmington 43
Andover 33
Perugia 32
Lawrence 31
Piscataway 24
Redmond 19
The Dalles 19
Turku 19
Los Angeles 17
Brussels 16
New York 16
Woodbridge 16
São Paulo 15
Ho Chi Minh City 14
Auburn Hills 13
Bucharest 12
Dallas 11
Orem 11
Falls Church 10
Helsinki 10
Hanoi 9
Shanghai 9
Chennai 8
London 8
Saint Petersburg 8
Chicago 7
Norwalk 7
Warsaw 7
Redwood City 6
Rio de Janeiro 6
Tashkent 6
Atlanta 5
Baghdad 5
Brasília 5
Brooklyn 5
Council Bluffs 5
Des Moines 5
Falkenstein 5
Lahore 5
Nuremberg 5
Stockholm 5
Tokyo 5
Vienna 5
Charlotte 4
Columbus 4
Curitiba 4
Dammam 4
Den Haag 4
Frankfurt am Main 4
Guangzhou 4
Izmir 4
Lausanne 4
Manaus 4
San Paolo di Civitate 4
Toronto 4
Amsterdam 3
Belo Horizonte 3
Bogotá 3
Da Nang 3
Denver 3
Hyderabad 3
Karbala 3
Limeira 3
Manchester 3
Medellín 3
Montevideo 3
Montreal 3
Phoenix 3
Piracicaba 3
Ribeirão Preto 3
Rome 3
Sulaymaniyah 3
Ajman 2
Al Hillah 2
Arraial do Cabo 2
Assisi 2
Bandung 2
Bishkek 2
Boston 2
Buenos Aires 2
Totale 2.839
Salva come PNG Salva come JPEG
Nome #
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif 148
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF). 146
Analisi del proteoma di carcinomi papillari della tiroide positivi per la mutazione BRAFV600E 144
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas. 132
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 131
Analisi del meccanismo dominante inibitorio esercitato in cis dalle mutazioni inattivanti D594V e G596R sulla mutazione attivante di BRAF V600E 127
Analysis of human MDM4 variants in papillary thyroid carcinomas reveals new potential markers of cancer properties. 126
Timing of breakfast does not influence therapeutic efficacy of liquid levothyroxine formulation 121
Etiopatogenesi dei carcinomi della tiroide che originano dall’epitelio follicolare 117
Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer 115
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. 114
Search of ret/ptc rearrangement and braf and ras mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of braf mutation and allowed to detect a new mutation of braf oncoprotein 110
Identification of differentially expressed proteins in papillary thyroid carcinomas with V600E mutation of BRAF 109
Medicina molecolare in chirurgia della tiroide 109
Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors 109
Caratterizzazione biochimica e molecolare della nuova mutazione BRAFV599Ins recentemente individuata in un carcinoma papillare della tiroide 106
Anti-htert sirna-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 106
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif. 105
BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas 105
Long glucocorticoid-induced leucine zipper regulates human thyroid cancer cell proliferation 104
Molecular dynamic simulations of the catalytic domain of BRAF in response to activating and inactivating mutations 103
Proteomic analysis of papillary thyroid carcinoma reveals demodulation of mechanisms regulating cell proliferation, susceptibility to oxidative stress and cellular aggregation 103
Braf mutation testing in fnac samples increases accuracy of thyroid cytology in a region of high braf mutation prevalence 96
INDOLEAMINE 2,3-DIOXYGENASE 1 (IDO1) IS UPREGULATED IN THYROID CARCINOMA AND DRIVES THE DEVELOPMENT OF AN IMMUNOSUPPRESSANT TUMOR MICROENVIRONMENT. 93
Sunitinib inhibits tumor vascularity and growth but does not affect Akt and ERK phosphorylation in xenograft tumors. 92
Le sostituzioni aminoacidiche G596R e D594V hanno un effetto inibitorio dominante sulla funzione della mutazione V600E di BRAF 90
Signal transducer and activator of transcription 1 plays a pivotal role in RET/PTC3 oncogene-induced expression of indoleamine 2,3-dioxygenase 1 90
Biochemical and molecular characterization of the novel BRAF(V599Ins) mutation detected in a classic papillary thyroid carcinoma. 88
Characterization of novel non-clonal intrachromosomal rearrangements between the H4 and PTEN genes (H4/PTEN) in human thyroid cell lines and papillary thyroid cancer specimens 87
Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma 86
EFFETTO DI DUE INIBITORI CHINASICI IN LINEE CELLULARI DI CARCINOMA TIROIDEO: STUDI IN VITRO E IN VIVO 85
Ret/PTC activation does not influence clinical and pathological features of adult papillary thyroid carcinomas. 83
Oncogeni e chirurgia della tiroide 82
Caratteristiche genetiche di una coorte di carcinomi papillari della tiroide raccolta in Umbria e loro significato clinico 82
Germline BRAF mutations in Noonan, LEOPARD and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum 80
Clinical prognosis in BRAF-mutated PTC 79
Microsomal prostaglandin E2 synthase-1 is induced by conditional expression of RET/PTC in thyroid PCCL3 cells through the activation of the MEK-ERK pathway 78
Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer. 77
Molecular dynamic simulation of the catalytic domain of BRAF in response to activating and inactivating mutation 76
Sunitinib inhibits the growth of thyroid tumor xenografts in mice by acting primarily on tumor angiogenesis 76
Search of RET/PTC rearrangement and BRAF and RAS mutations in a umbrian papillary thyroid carcinoma cohort showed high prevalence of BRAF mutation and allowed to detect a new mutation of BRAF oncoprotein 75
Synthesis of phosphatidylserine by base exchange in rat cerebellum and cortex 74
Sunitinib exerts only limited effects on the proliferation and differentiation of anaplastic thyroid cancer cells 73
RET/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response 68
Targeted molecular therapies in thyroid carcinoma. 66
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 62
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAF(V600E) mutation 61
L’INIBIZIONE DI IDO1 (INDOLEAMMINA 2,3-DIOSSIGENASI 1) RIDUCE LA PROLIFERAZIONE DELLE CELLULE FTC133 57
Classification of thyroid diseases using machine learning and Bayesian graph algorithms 53
Wnt/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer 52
Inactivating D594V and G596R amino acid substitutions have a dominant inhibitory effect on the V600E activating mutation of BRAF. 52
Predictors of response to lenvatinib in advanced differentiated thyroid cancer: focus on the CONUT score 14
Totale 4.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.090
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.090
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021149 0 0 0 0 0 0 0 0 0 22 51 76
2021/2022446 16 74 10 43 9 3 7 145 2 23 44 70
2022/2023740 61 147 7 77 62 68 0 40 246 1 26 5
2023/2024267 24 32 9 5 3 2 43 18 49 7 46 29
2024/2025742 15 67 68 20 73 33 6 64 140 40 146 70
2025/20261.445 110 116 68 168 188 134 237 80 225 119 0 0
Totale 4.817